Congenital muscular dystrophy with primary partial laminin α2 chain deficiency:: Molecular study

被引:26
作者
He, Y
Jones, KJ
Vignier, N
Morgan, G
Chevallay, M
Barois, A
Estournet-Mathiaud, B
Hori, H
Mizuta, T
Tomé, FMS
North, KN
Guicheney, P
机构
[1] Grp Hosp Pitie Salpetriere, Inst Myol, INSERM, U523, F-75634 Paris, France
[2] Grp Hosp Pitie Salpetriere, IFR Coeur Muscle & Vaisseaux 14, F-75634 Paris, France
[3] Hop Ray Poincare, Serv Pediat Reanimat Infantile, Garches, France
[4] Childrens Hosp, Inst Neuromuscular Res, Sydney, NSW, Australia
[5] Univ Sydney, Dept Paediat & Child Hlth, Randwick, NSW, Australia
[6] Sydney Childrens Hosp, Randwick, NSW, Australia
[7] Tokyo Med & Dent Univ, Inst Med Res, Tokyo, Japan
[8] Saga Med Sch, Dept Internal Med, Nabeshima, Japan
关键词
D O I
10.1212/WNL.57.7.1319
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The authors report a case of congenital muscular dystrophy with mild nonprogressive muscle weakness, white matter hypodensity, and absence of the laminin alpha2 chain in muscle fibers with two antibodies, but not with four others. They identified mutations in LAMA2, which explain the partial laminin alpha2 deficiency. Analysis of this case and two others allows us to refine the epitopes of two of the commercial antibodies, and illustrate the importance of using antibodies directed against different domains of the protein.
引用
收藏
页码:1319 / 1322
页数:4
相关论文
共 10 条
[1]   Mild congenital muscular dystrophy in two patients with an internally deleted laminin alpha 2-chain [J].
Allamand, V ;
Sunada, Y ;
Salih, MAM ;
Straub, V ;
Ozo, CO ;
AlTuraiki, MHS ;
Akbar, M ;
Kolo, T ;
Colognato, H ;
Zhang, X ;
Sorokin, LM ;
Yurchenco, PD ;
Tryggvason, K ;
Campbell, KP .
HUMAN MOLECULAR GENETICS, 1997, 6 (05) :747-752
[2]  
BROWN JC, 1994, J CELL SCI, V107, P329
[3]  
Dubowitz V, 1999, Neuromuscul Disord, V9, P446
[4]   PCR based mutation screening of the laminin α2 chain gene (LAMA2):: application to prenatal diagnosis and search for founder effects in congenital muscular dystrophy [J].
Guicheney, P ;
Vignier, N ;
Zhang, X ;
He, Y ;
Cruaud, C ;
Frey, V ;
Helbling-Leclerc, A ;
Richard, P ;
Estournet, B ;
Merlini, L ;
Topaloglu, H ;
Mora, M ;
Harpey, JP ;
Haenggeli, CA ;
Barois, A ;
Hainque, B ;
Schwartz, K ;
Tome, FMS ;
Fardeau, M ;
Tryggvason, K .
JOURNAL OF MEDICAL GENETICS, 1998, 35 (03) :211-217
[5]   HUMAN LAMININ M-CHAIN - EPITOPE ANALYSIS OF ITS MONOCLONAL-ANTIBODIES BY IMMUNOSCREENING OF CDNA CLONES AND TISSUE EXPRESSION [J].
HORI, H ;
KANAMORI, T ;
MIZUTA, T ;
YAMAGUCHI, N ;
LIU, Y ;
NAGAI, Y .
JOURNAL OF BIOCHEMISTRY, 1994, 116 (06) :1212-1219
[6]   Abnormalities of dystrophin, the sarcoglycans, and laminin α2 in the muscular dystrophies [J].
Jones, KJ ;
Kim, SS ;
North, KN .
JOURNAL OF MEDICAL GENETICS, 1998, 35 (05) :379-386
[7]   Characterization of monoclonal antibodies recognizing human merosin and their use in affinity purification of native merosin [J].
Mizuta, T ;
Shimada, H ;
Arai, K ;
Hori, H ;
Hattori, S ;
Yamamoto, K ;
Sakai, T ;
Nagai, Y .
HYBRIDOMA, 1996, 15 (05) :373-378
[8]   Structural analysis and proteolytic processing of recombinant G domain of mouse laminin α2 chain [J].
Talts, JF ;
Mann, K ;
Yamada, Y ;
Timpl, R .
FEBS LETTERS, 1998, 426 (01) :71-76
[9]  
TOME FMS, 1998, NEUROMUSCULAR DISORD, P21
[10]   Congenital muscular dystrophies: 1997 update [J].
Voit, T .
BRAIN & DEVELOPMENT, 1998, 20 (02) :65-74